GLAS GLAS
Company Profile ↓Company Overview
GLAS (GLAS) is a publicly traded company listed on with a market capitalization of $756.81M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 28.9% CAGR over the past five years.
Recent Developments
- Dec 2025 Revenue of $181.98M (-9.4% YoY); net profit $-29.66M.
- Trailing 12 Months Year-on-year growth — revenue -9.4%.
- 5-Year Trend Long-term compounding — revenue CAGR 28.9%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 28.95% |
| 1 Year: | -9.41% |
Stock Price Performance
| 1 Year: | +56.82% |
| 6 Months: | +3.35% |
| 3 Months: | -4.73% |
| 1 Month: | -19.90% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMAAbove
- RSI (14)36.22 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 28.9% over 5 years.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading 31.8% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 44.82M | 59.87M | 38.44M | 38.85M | 38.85M |
| Cost of Revenue | - | 24.75M | 27.94M | 26.69M | 25.65M | 25.65M |
| Gross Profit | - | 20.07M | 31.93M | 11.76M | 13.21M | 13.21M |
| Operating Expenses | - | 21.27M | 21.29M | 23.14M | 25.89M | 25.89M |
| Operating Income | - | -1.21M | 10.64M | -11.38M | -12.68M | -12.68M |
| EBITDA | - | -967.00K | 19.54M | -5.30M | -7.46M | -7.46M |
| Interest Expense | - | 2.28M | 1.92M | 1.82M | 1.04M | 1.04M |
| Pretax Income | - | -7.08M | 13.71M | -11.12M | -12.53M | -12.53M |
| Tax Provision | - | 2.93M | 4.97M | 1.07M | 2.97M | 2.97M |
| Net Income | - | -10.01M | 8.67M | -12.29M | -15.97M | -15.50M |
| Diluted EPS | - | -0.13 | 0.05 | -0.19 | -0.19 | -0.18 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 84.87M | 160.84M | 200.90M | 181.98M |
| Cost of Revenue | - | 64.16M | 79.87M | 103.50M | 105.02M |
| Gross Profit | - | 20.71M | 80.97M | 97.39M | 76.96M |
| Operating Expenses | - | 71.25M | 77.68M | 85.36M | 91.59M |
| Operating Income | - | -50.54M | 3.29M | 12.04M | -14.63M |
| EBITDA | - | -17.44M | -63.67M | 35.45M | 5.80M |
| Interest Expense | - | 7.61M | 9.82M | 9.18M | 7.06M |
| Pretax Income | - | -37.35M | -88.12M | 11.22M | -17.02M |
| Tax Provision | - | -4.39M | 9.94M | 10.50M | 11.93M |
| Net Income | - | -32.90M | -98.27M | 519.00K | -29.66M |
| Diluted EPS | - | -0.83 | -1.37 | 0.01 | -0.35 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 350.63M | 303.77M | 310.50M | 318.56M |
| Current Assets | - | 38.89M | 49.22M | 66.10M | 67.75M |
| Cash & Equivalents | - | 11.14M | 29.52M | 33.92M | 19.85M |
| Inventory | - | 10.95M | 8.84M | 14.25M | 26.23M |
| Receivables | - | 4.79M | 3.98M | 5.22M | 4.42M |
| Total Liabilities | - | 129.49M | 158.54M | 146.45M | 221.46M |
| Current Liabilities | - | 54.00M | 87.36M | 66.48M | 37.96M |
| Long Term Debt | - | 62.62M | 56.51M | 50.55M | 68.63M |
| Total Debt | - | 73.88M | 75.13M | 69.20M | 74.57M |
| Total Equity | - | 168.86M | 89.76M | 116.24M | 73.94M |
| Shares Outstanding | - | 68.22M | 70.94M | 76.91M | 81.73M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -40.78M | 23.22M | 28.39M | 11.45M |
| Investing Cash Flow | - | -29.20M | -12.71M | -10.29M | -27.74M |
| Financing Cash Flow | - | 30.06M | 7.87M | -13.70M | 2.72M |
| Capital Expenditure | - | -27.77M | -12.31M | -10.29M | -27.18M |
| Free Cash Flow | - | -68.55M | 10.91M | 18.10M | -15.73M |
| Net Change in Cash | - | -39.92M | 18.38M | 4.40M | -13.57M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 24.4% | 50.3% | 48.5% | 42.3% |
| Operating Margin % | - | -59.6% | 2.0% | 6.0% | -8.0% |
| Net Margin % | - | -38.8% | -61.1% | 0.3% | -16.3% |
| ROE % | - | -19.5% | -109.5% | 0.4% | -40.1% |
| ROCE % | - | -17.0% | 1.5% | 4.9% | -5.2% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for GLAS
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE9fd2dYUGpyZ0haQ2NidUZZMW5sdGwycm8zbi1PSFBDSEFtalczLWpqNVNhOGUwYnVDQ1RObmp5OF9nT0h1bDVrdVBmdVhfdVB1?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
Enterprise value to EBITDA forward of PGP Glass Ceylon PLC – CSELK:GLAS.N0000 - TradingView
<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxQV215dzNyRl82SVRGbDllajV3SWFIUUdxU2U5aV9rVDVLdkF2N1ZmakVManNtOXJfY21ibGNyTXpMMFFVWVgtd3E3eXMtNXZ1Q2F0Z3dQcHBoajFUamNjMEpKUFE1WkFxOUVvdGlrczk3Qk1HUDBnQWVlNzZUZF8zOWstN05LNndMWmtjQ3…
Glass House Brands (GLAS) Stock Price, News & Analysis - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTE1vbVBQV3EyendfdG40VklENm9pUVMwbjJqVmhIcHF2NWh0NEtQV19mckFOTWJ2X25iWEhJbUVhVkNpalJ2eGdwLVk2bnV6d1dTblc4?oc=5" target="_blank">Glass House Brands (GLAS) Stock Price, News & Analysis<…
Glass House Brands Announces Uplist to NYSE; Trading Expected June 30 - Cannabis Business Times
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxONDI3eEUybC02anNkelBsQlVibHRxOUtkb1hua0ZaQi1qeTlhTnVoTFE1M01uUmZjdnZBMm1KLUxzWGY3SW16ZF9xdGxHY3Z5LWFUek1MR3pIVkQ3TUJWdVdBNFYzLUhNZ1RIQm9rT255Wi1JcG5yTXhZUWwxQ3dLbTdiSTZ2WkNsRFRSNy…
Santa Barbara County Cannabis Company ‘Uplisted’ to New York Stock Exchange - independent.com
<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxOY1JEWWpUWUpEM1V4ZWwyeXlhZjVpcEdVeTZ3emF5b3d3YnJKM1lvZ0g0enQyY0FEQVZWZ0lmakoyRURxNGo3TWZTUVNaYS1FdWYwUEE2QkFaZENhbkx1azFVb0xiVjNLQzBySjdXcDZoSEVTaGNfUEFRdktrdkJSaklWcXNQUEducHoxRE…
Glass House Brands Announces Uplist to NYSE - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxOcGRpcXVxZDVBak8tV2ppSW5kN2pPdVk1d3hBTEtLZTJIZHpuZ2RGM1hVbFBDWmYyZkx4RDE4azhfXzhZeXdNRHBJNGotaXd3WkRydE1ORll6bFIwUEVyOXBPeF91UFlNV3VtOGVSc3pRWmF3WF91YkdGNUpTSkpJMUpuWEFBTTNHdVl6dU…
GLAS — Frequently Asked Questions
What is the current share price of GLAS?
As of 2026-08-05 17:25 PDT, GLAS trades at $9.26 on NASDAQ/NYSE. Its 52-week range is $5.31 to $13.58.
What is the market capitalisation of GLAS?
GLAS has a market capitalisation of $756.81M on NASDAQ/NYSE.
What is the P/E ratio of GLAS?
GLAS trades at a trailing price-to-earnings (P/E) ratio of -26.14. Its price-to-book (P/B) ratio is 10.24.
What is the return on equity (ROE) of GLAS?
GLAS has a return on equity (ROE) of -40.11%. Its return on capital employed (ROCE) is -5.21%.
Is GLAS a good stock to buy?
This page provides a data-driven analysis of GLAS, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.